TRANSCODE THERAPEUTICS INC (RNAZ) Stock News
NASDAQ:RNAZ - Nasdaq - US89357L3033 - Common Stock - Currency: USD
RNAZ Latest News and Analysis
Which stocks are moving on Thursday?
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Thursday's session: top gainers and losers
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Which stocks are moving before the opening bell on Thursday?
As the US market prepares to open on Thursday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Here are the top movers in Wednesday's session.
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
What's going on in today's session
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
The trading volume of these stocks is deviating from the norm in today's session.
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the stocks with an unusual volume in today's session.
Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Unusual volume stocks are being observed in Tuesday's session.
Let's have a look at the stocks with an unusual volume in today's session.
These stocks are moving in today's session
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.
The market is filled with gapping stocks in Tuesday's session.
The market is buzzing with gapping stocks on Tuesday. Let's uncover which stocks are experiencing notable gaps during today's session.
On Friday, there are stocks with unusual volume. Let's take a look.
Unusual volume stocks are being observed in Friday's session.
Which stocks are moving before the opening bell on Friday?
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
These stocks are moving in today's session
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split...
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
TransCode Therapeutics, Inc. Announces $8 Million Private Placement...
TransCode Therapeutics Announces 1-for-33 Reverse Stock Split
Split designed to achieve compliance with Nasdaq minimum bid price requirements
TransCode Therapeutics Announces 1-for-33 Reverse Stock Split
TransCode Therapeutics Announces 1-for-33 Reverse Stock Split...
TransCode Therapeutics Open Letter to Shareholders
TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance
TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance
TransCode Therapeutics Announces Nasdaq Extension to Re-gain Compliance ...
TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology
TransCode Therapeutics Completes Initial Dosing of First Cohort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology
TransCode Therapeutics Completes Initial Dosing of First Co-hort in Phase 1 Clinical Trial with TTX-MC138, a microRNA-Targeted Technology ...
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate...